Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Vyome Holdings, Inc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 11 | 17 | +6 |
| Shares | 103.7K | 403.7K | +300.0K (+289.2%) |
| Value | $153.5K | $134.7K | −$18.8K (−12.3%) |
New holders (7)
Institutions that held Vyome Holdings, Inc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 188,000 | $63.5K | 0.00% |
| Baader Bank INC | 42,050 | $12.7K | 0.00% |
| Renaissance Technologies LLC | 20,500 | $7.00K | 0.00% |
| Geode Capital Management, LLC | 18,348 | $6.20K | 0.00% |
| Virtu Financial LLC | 18,601 | $6.00K | 0.00% |
| Two Sigma Securities, LLC | 13,802 | $4.67K | 0.00% |
| Bank of America Corp | 100 | $34 | 0.00% |
Sold out (1)
Institutions that held Vyome Holdings, Inc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| JPMorgan Chase & Co | 1,859 | $2.75K |